<DOC>
	<DOCNO>NCT00557362</DOCNO>
	<brief_summary>We evaluate whether voriconazole superior treatment natamycin filamentous fungal keratitis randomize , mask , control trial . This therapeutic exploratory study investigate safety feasibility conduct large study generate preliminary data .</brief_summary>
	<brief_title>Therapeutic Exploratory Study Comparing Natamycin Voriconazole Treat Fungal Corneal Ulcer</brief_title>
	<detailed_description>Fungal ulcer tend poor outcome common treatment , amphotericin B natamycin . There single randomize trial anti-fungal therapy fungal ulcer new medication approve FDA since 1960s . There study indicate new triazoles , voriconazole , effective vitro filamentous fungi Aspergillus spp. , common cause fungal keratitis1-3 . Despite number case report vitro study , systematic attempt determine whether less effective clinically natamycin , commercially available FDA-approved agent . There little data available physician make inform , evidence-based decision choice antifungal . We evaluate whether voriconazole superior treatment natamycin filamentous fungal keratitis randomize , mask , control trial . This therapeutic exploratory study investigate safety feasibility conduct large study generate preliminary data . The primary outcome visual acuity 3 month enrollment . A subset patient follow 4 year enrollment .</detailed_description>
	<mesh_term>Keratitis</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<mesh_term>Natamycin</mesh_term>
	<criteria>Presence corneal ulcer presentation Evidence filamentous fungus KOH ( Giemsa stain ) culture The patient must able verbalize basic understanding study explain patient , determine physician examiner . This understanding must include commitment return followup visit . Willingness treat inpatient treat outpatient come back every 4872 hour receive fresh medication 3 week Appropriate consent Overlying epithelial defect &lt; 0.5 mm great width presentation Impending perforation Evidence bacteria Gram stain time enrollment Evidence acanthamoeba stain Evidence herpetic keratitis history exam Corneal scar easily distinguishable current ulcer Age le 16 year ( 16th birthday ) Bilateral ulcer Previous penetrate keratoplasty affect eye Pregnancy ( history urine test ) breastfeeding ( history ) Acuity worse 6/60 ( 20/200 ) fellow eye ( note acuity , uncorrected , correct , pinhole , BSCVA 6/60 good qualifies enrollment ) Known allergy study medication ( antifungal preservative ) No light perception affect eye Not willing participate</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Keratitis</keyword>
	<keyword>Eye Infection , Fungal</keyword>
	<keyword>Fungal Eye Infection</keyword>
	<keyword>Ocular Infection , Fungal</keyword>
	<keyword>Fungal Keratitis</keyword>
	<keyword>Mycotic Infections , Ocular</keyword>
	<keyword>Voriconazole</keyword>
	<keyword>Natamycin</keyword>
</DOC>